8 - 2026 - Cell La Vie

12АвгАвгуст 12, 2026

MSC Therapy for Peripheral Arterial Disease and Critical Limb Ischemia: 2026 Clinical and Mechanistic Breakthroughs

CRISPR-edited MSCs, iPSC-derived cells, combinatorial cell therapy, and exosome-based approaches are transforming PAD/CLI treatment. Six landmark 2026 papers and five active clinical trials reviewed for clinicians and researchers.

МСК, Стволовые клеткиМСК, регенеративная медицина, стволовая клетка, стволовые клетки0 комментариев

12АвгАвгуст 12, 2026

MSC Therapy for Pulmonary Arterial Hypertension: Mechanisms, Mitochondrial Repair.

Pulmonary arterial hypertension kills half its patients within five years. 2026 research shows mesenchymal stem cells — especially HO-1-modified and mitochondria-primed MSCs — are reversing the vascular remodeling at the disease’s core. Here’s the science behind the breakthrough.

МСК, Стволовые клеткимезенхимальный, МСК, регенеративная медицина, стволовая клетка, стволовые клетки0 комментариев

12АвгАвгуст 12, 2026

Can Stem Cell Exosomes Restore Hearing? What the 2026 Breakthrough Means for You

A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be available.

Exosome, МСК, Стволовые клеткиМСК, восстановление, регенеративная медицина, стволовая клетка, стволовые клетки0 комментариев